Radnor Capital Management, LLC Merck & Co., Inc. Transaction History

Radnor Capital Management, LLC

$328 Million
Q2 2024

A detailed history of Radnor Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Radnor Capital Management, LLC holds 519,683 shares of MRK stock, worth $59 Million. This represents 19.62% of its overall portfolio holdings.

Number of Shares

519,683

Previous 529,601 1.87%

Holding current value

$59 Million

Previous $69.9 Million 7.93%

% of portfolio

19.62%

Previous 11.92%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$123.8 - $132.96 $1.23 Million - $1.32 Million	-9,918 Reduced 1.87%	519,683 $64.3 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $2.03 Million - $2.37 Million	-17,933 Reduced 3.28%	529,601 $69.9 Million
Q4 2023 Jan 11, 2024	SELL	$100.18 - $109.02 $1.73 Million - $1.88 Million	-17,248 Reduced 3.05%	547,534 $59.7 Million
Q3 2023 Oct 12, 2023	SELL	$102.95 - $114.33 $709,840 - $788,305	-6,895 Reduced 1.21%	564,782 $58.1 Million
Q2 2023 Jul 07, 2023	SELL	$108.61 - $118.38 $1.68 Million - $1.83 Million	-15,468 Reduced 2.63%	571,677 $66 Million
Q1 2023 Apr 06, 2023	SELL	$102.94 - $114.86 $698,242 - $779,095	-6,783 Reduced 1.14%	587,145 $62.5 Million
Q4 2022 Jan 09, 2023	SELL	$87.44 - $112.11 $62,082 - $79,598	-710 Reduced 0.12%	593,928 $65.9 Million
Q3 2022 Oct 12, 2022	BUY	$84.53 - $94.96 $23,752 - $26,683	281 Added 0.05%	594,638 $51.2 Million
Q2 2022 Jul 11, 2022	SELL	$83.49 - $94.64 $1.71 Million - $1.94 Million	-20,521 Reduced 3.34%	594,357 $54.2 Million
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $2.15 Million - $2.41 Million	-29,280 Reduced 4.55%	614,878 $50.5 Million
Q4 2021 Jan 20, 2022	SELL	$72.28 - $90.54 $1.11 Million - $1.39 Million	-15,383 Reduced 2.33%	644,158 $49.4 Million
Q3 2021 Oct 26, 2021	BUY	$71.68 - $78.83 $3.02 Million - $3.32 Million	42,158 Added 6.83%	659,541 $49.5 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $73,825 - $81,658	1,050 Added 0.17%	617,383 $48 Million
Q1 2021 Apr 26, 2021	SELL	$68.86 - $81.11 $22.7 Million - $26.7 Million	-329,136 Reduced 34.81%	616,333 $47.5 Million
Q4 2020 Jan 13, 2021	BUY	$71.77 - $79.65 $24.1 Million - $26.8 Million	335,856 Added 55.09%	945,469 $77.3 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $145,042 - $164,406	-1,982 Reduced 0.32%	609,613 $50.6 Million
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $83,236 - $94,713	-1,182 Reduced 0.19%	611,595 $47.8 Million
Q1 2020 Apr 07, 2020	SELL	$63.36 - $87.82 $1.13 Million - $1.57 Million	-17,900 Reduced 2.84%	612,777 $47.1 Million
Q4 2019 Jan 10, 2020	SELL	$77.58 - $87.54 $404,346 - $456,258	-5,212 Reduced 0.82%	630,677 $57.4 Million
Q3 2019 Oct 07, 2019	BUY	$76.08 - $82.93 $404,973 - $441,436	5,323 Added 0.84%	635,889 $53.5 Million
Q2 2019 Jul 18, 2019	SELL	$69.84 - $81.59 $1.58 Million - $1.84 Million	-22,605 Reduced 3.46%	630,566 $52.9 Million
Q1 2019 Apr 25, 2019	SELL	$69.58 - $79.36 $2.3 Million - $2.62 Million	-33,060 Reduced 4.82%	653,171 $54.3 Million
Q4 2018 Jan 16, 2019	SELL	$65.24 - $75.71 $649,986 - $754,298	-9,963 Reduced 1.43%	686,231 $52.4 Million
Q3 2018 Oct 04, 2018	BUY	$57.69 - $67.84 $834,716 - $981,576	14,469 Added 2.12%	696,194 $49.4 Million
Q2 2018 Jul 10, 2018	SELL	$50.83 - $59.72 $1.97 Million - $2.32 Million	-38,770 Reduced 5.38%	681,725 $41.4 Million
Q1 2018 Apr 20, 2018	SELL	$50.96 - $59.23 $68,031 - $79,072	-1,335 Reduced 0.18%	720,495 $39.2 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $24,261 - $28,970	470 Added 0.07%	721,830 $40.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	721,360	721,360 $46.2 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Merck & Co., Inc. Transaction History